期刊
出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.2102178118
关键词
biased agonism; tolerance; naloxone; efficacy; allostery
资金
- National Institutes on Drug Abuse [NIH R01DA038964, R01DA033073, F32DA052124]
G protein-biased mu opioid receptor agonists demonstrate stability in a wash-resistant signaling state and reversibility by antagonists. These biased agonists stimulate G protein signaling in mouse brains without competing with full agonist activation.
The ability of a ligand to preferentially promote engagement of one signaling pathway over another downstream of GPCR activation has been referred to as signaling bias, functional selectivity, and biased agonism. The presentation of ligand bias reflects selectivity between active states of the receptor, which may result in the display of preferential engagement with one signaling pathway over another. In this study, we provide evidence that the G protein-biased mu opioid receptor (MOR) agonists SR-17018 and SR-14968 stabilize the MOR in a wash-resistant yet antagonist-reversible G protein-signaling state. Furthermore, we demonstrate that these structurally related biased agonists are noncompetitive for radiolabeled MOR antagonist binding, and while they stimulate G protein signaling in mouse brains, partial agonists of this class do not compete with full agonist activation. Importantly, opioid antagonists can readily reverse their effects in vivo. Given that chronic treatment with SR-17018 does not lead to tolerance in several mouse pain models, this feature may be desirable for the development of long-lasting opioid analgesics that remain sensitive to antagonist reversal of respiratory suppression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据